- Cardano (ADA) Price Eyes Breakout as Bulls Challenge Key Resistance Near $0.22
- ATOM Price Leads DeFi Rally as Traders Bet on Cosmos Recovery
- U.S. stocks move丨Zebra Technologies rises over 11% in pre-market trading
- UBS Group: Adidas target price lowered from 219 euros to 173 euros.
- US ISM Manufacturing PMI Hits 4-Year High; Stock and Crypto Markets Eye Rally
- PENSKE AUTOMOTIVE GROUP INC : JP MORGAN RAISES TARGET PRICE TO $215 FROM $170
- Buzzi H1 FY26 net profit drops 16.8% to EUR 324 million; net sales edge up 0.1% to EUR 2.19 billion
- LITHIA & DRIVEWAY <LAD.N>: JP MORGAN RAISES TARGET PRICE TO $340 FROM $325
- GROUP 1 AUTOMOTIVE INC <GPI.N>: JP MORGAN CUTS TARGET PRICE TO $275 FROM $320
- AUTONATION : JP MORGAN CUTS TARGET PRICE TO $210 FROM $235
- Snap Inc. Stock Jumps 5% on 19% Revenue Growth, Hits Key Resistance
- Brightstar Q2 GAAP operating income turns to USD 56 million; revenue drops 7% year over year to USD 584 million
- ASBURY AUTOMOTIVE GROUP INC : JP MORGAN CUTS TARGET PRICE TO $190 FROM $220
- VALERO ENERGY CORP <VLO.N>: MIZUHO RAISES TARGET PRICE TO $300 FROM $289
- GEORGE WESTON LTD <WN.TO>: SCOTIABANK RAISES TARGET PRICE TO C$112 FROM C$102
- PBF ENERGY INC : MIZUHO RAISES TARGET PRICE TO $65 FROM $57
- CLOROX <CLX.N>: RBC CUTS TARGET PRICE TO $110 FROM $118
- HF SINCLAIR CORP <DINO.N>: MIZUHO RAISES TARGET PRICE TO $85 FROM $79
- Jones Soda schedules second-quarter earnings conference call
- MM2 Asia moratorium extended to Sept. 21 under Singapore restructuring law
- WELL Health appoints Loreto Grimaldi chief legal officer
- Resideo to spin off ADI Global Distribution, list shares on NYSE as ADIG
- PALANTIR TECHNOLOGIES INC : MIZUHO RAISES TARGET PRICE TO $215 FROM $185
- Westlake Q2 FY26 net income swings to USD 260 million; net sales rise 10.77% to USD 3.27 billion
- Caterpillar 2Q26 profit per share climbs 68% to $7.77; sales and revenues rise 24% to $20.5B
- ONSEMI <ON.O>: MIZUHO CUTS TARGET PRICE TO $110 FROM $125
- NEXTPOWER INC <NXT.O>: MIZUHO CUTS TARGET PRICE TO $111 FROM $142
- MASTEC INC <MTZ.N>: MIZUHO CUTS TARGET PRICE TO $457 FROM $502
- Cat Financial Q2 profit rises 6% to $145 million
- Headwater Gold, Newmont sign Spring Peak joint venture agreement in Nevada
- MARRIOTT <MAR.O>: MIZUHO CUTS TARGET PRICE TO $374 FROM $384
- INSPIRE MEDICAL SYSTEMS INC <INSP.N>: MIZUHO RAISES TARGET PRICE TO $65 FROM $55
- FAIR ISAAC CORP <FICO.N>: MIZUHO CUTS TARGET PRICE TO $1344 FROM $1494
- IDEXX Q2 FY26 EPS rises 18% to $4.27; revenue increases 10% to USD 1.22 billion
- Hyperscale Data forecasts 2027 revenue of $300 million-$350 million
- InfuSystem Q2 FY26 net income rises 24% to $3.2 million; revenue increases 2.6% to $36.9 million
- Trex Q2 FY26 net income falls 18.5% to $62 million; net sales rise 8% to $418 million
- Vivid Seats Q2 FY26 net loss widens to $14.32 million; revenue falls to $129.86 million
- Willis Lease Finance Q2 FY26 net income attributable to common shareholders drops 51.2% to $28.75 million; revenue slips 0.8% to $194.02 million
- Apollo GAAP net income rises to $1.34 billion in FY26 Q2; revenue climbs to $11.15 billion
- Westlake Chemical Partners Q2 FY26 net income slips to $14.24 million; net sales hold at $297.1 million
- ON SEMICONDUCTOR CORPORATION <ON.O>: WELLS FARGO CUTS TARGET PRICE TO $110 FROM $130
- IBOTTA, INC. <IBTA.N>: WELLS FARGO RAISES TARGET PRICE TO $40 FROM $38
- SNAP, INC. <SNAP.N>: WELLS FARGO RAISES TARGET PRICE TO $6 FROM $5
- OLIN CORPORATION <OLN.N>: WELLS FARGO CUTS TARGET PRICE TO $20 FROM $25
- HUNTSMAN CORPORATION <HUN.N>: WELLS FARGO CUTS TARGET PRICE TO $11 FROM $14
- HUNTINGTON INGALLS INDUSTRIES, INC. <HII.N>: WELLS FARGO RAISES TARGET PRICE TO $340 FROM $325
- GENERAL DYNAMICS CORPORATION <GD.N>: WELLS FARGO RAISES TARGET PRICE TO $440 FROM $400
- CARPENTER TECHNOLOGY CORPORATION <CRS.N>: WELLS FARGO RAISES TARGET PRICE TO $540 FROM $425
- ARXIS, INC. : WELLS FARGO RAISES TARGET PRICE TO $63 FROM $52
- D.R. HORTON, INC. <DHI.N>: WELLS FARGO CUTS TARGET PRICE TO $155 FROM $170
- MOBILITY GLOBAL INC. <MBGL.N>: WELLS FARGO CUTS TARGET PRICE TO $25 FROM $27
- INTEGER HOLDINGS CORPORATION <ITGR.N>: WELLS FARGO RAISES TARGET PRICE TO $127 FROM $84
- KEROS THERAPEUTICS, INC. <KROS.O>: WELLS FARGO CUTS TARGET PRICE TO $18 FROM $20
- WEALTHFRONT CORPORATION <WLTH.O>: WELLS FARGO CUTS TARGET PRICE TO $11.5 FROM $12
- THE CLOROX COMPANY <CLX.N>: WELLS FARGO RAISES TARGET PRICE TO $102 FROM $95
- MARRIOTT INTERNATIONAL, INC. <MAR.O>: WELLS FARGO CUTS TARGET PRICE TO $425 FROM $449
- Barnwell Industries sells remaining Hawaii development interests for USD 1.77 million
- BRIEF-Chatham Lodging Trust Q2 EPS USD 0.13
- BRIEF-Caterpillar Q2 Adjusted EPS USD 8.17 Vs. IBES Estimate USD 6.2
- BRIEF-Westlake Q2 EPS USD 2.01
- BRIEF-Graphic Packaging Q2 EPS USD 0.08
- BRIEF-Trex Company Q2 Adjusted EPS USD 0.62 Vs. IBES Estimate USD 0.63
- BRIEF-EnPro Industries Q2 Adjusted EPS USD 2.5 Vs. IBES Estimate USD 2.32
- BRIEF-IDEXX Q2 EPS USD 4.27
- BRIEF-Kimberly-Clark Q2 Adjusted EPS USD 2.12 Vs. IBES Estimate USD 2.01
- BRIEF-Hut 8 Corp Q2 Revenue USD 74.932 Million Vs. IBES Estimate USD 80.7 Million
- BRIEF-Vivid Seats Q2 Revenue USD 129.9 Million Vs. IBES Estimate USD 122.6 Million
- BRIEF-Westlake Chemical Partners Q2 Net Income USD 82.362 Million
- Westlake 2Q EBITDA $679M >WLK
- Enpro Sees 2026 Rev $330M-$340M >NPO
- Apollo Global: Our Strong 2Q Results Reflect Record Earnings Across Asset Management and Retirement Services >APO
- Apollo Global Declares Qtr Dividend of 56.25c/Share >APO
- Apollo Global Total Assets Under Management as of June 30 $1.05 Trillion >APO
- Apollo Global 2Q Fee-Related Earnings $785M, or $1.26/Share >APO
- Apollo Global 2Q Spread-Related Earnings $877M, or $1.41/Share >APO
- Apollo Global 2Q Rev $11.15B >APO
- Apollo Global 2Q Adj EPS $2.11 >APO
- Apollo Global 2Q EPS $2.15 >APO
- IDEXX Labs Sees 2026 Rev $4.7B-$4.745B >IDXX
- BRIEF-Zebra Technologies Q2 Adjusted EPS USD 6.35 Vs. IBES Estimate USD 4.36
- BRIEF-Apollo Global Management Q2 Adjusted EPS USD 1.92 Vs. IBES Estimate USD 2.17
- Trex: Additional $150M Stock Buyback Approved
- Apollo declares $0.56 quarterly dividend per share
- Kimberly-Clark 2Q International Personal Care Net Sales $1.5B, Up 4% >KMB
- Vivid Seats 2Q Rev $129.9M >SEAT
- Chatham Lodging Trust 2Q EPS 13c >CLDT
- Hyperscale Data Sees 2027 Rev $300M-$350M >GPUS
- InfuSystem 2Q Rev $36.9M >INFU
- Chatham Lodging Trust 2Q Net $8.21M >CLDT
- Trex Co 2Q EPS 60c >TREX
- Enpro 2Q EPS $1.27 >NPO
- Westlake 2Q Sales $3.27B >WLK
- IDEXX Labs 2Q EPS $4.27 >IDXX
- Merck: MK-4208, Formerly TERN-701, Is Novel Investigational Oral Allosteric BCR::ABL1 Tyrosine Kinase Inhibitor Recently Granted BTD by FDA for Treatment of Certain Adults With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia >MRK
- Kimberly-Clark 2Q EPS $1.04 >KMB
- Kimberly-Clark 2Q Sales $4.19B >KMB
- Kimberly-Clark 2Q Adj EPS $2.12 >KMB
- Kimberly-Clark 2Q Cont Ops EPS $1.22 >KMB
- Kimberly-Clark 2Q Adj EPS From Cont Ops $1.80 >KMB
